The Defense Health Agency awarded a single award Indefinite Delivery Contract to Gen-Probe Incorporated to provide COVID-19 testing services and supplies. Under the contract, Gen-Probe will supply its APTIMA SARS-COV-2 ASSAY test kits, which have received Emergency Use Authorization from the FDA. Two firm fixed price delivery orders were issued against the IDC. The first was awarded on January 27, 2022 for $552,691.20 to provide 250 APTIMA test kits for use in Marlborough, Massachusetts from...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide COVID-19 testing equipment, supplies, and associated services to support the agency's pandemic response efforts. The initial BPA call was awarded on August 29, 2020 for COVID-19 testing stations and kits, with a potential value of $0 and a completion date of August 28, 2021. A subsequent BPA call for nucleic acid testing of...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Defense's Medical Command (MEDCOM) to Gen-Probe Incorporated, a medical diagnostics company. The contract has a ceiling value of $4,688,500 and was originally awarded on August 20, 2015, with a period of performance through September 30, 2020. Under this IDC, Gen-Probe has been tasked with providing PANTHER equipment, test kits, and reagents to support MEDCOM's medical programs, including for the detection of...
This is a single-award Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases. The contract, valued at $900,000.00, is for the provision of SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) test kits. The awarded task order, valued at $197,065.00, is for the delivery of SARS-CoV-2 IgG testing services to the VA's Veterans Integrated...
The U.S. Defense Health Agency has awarded a single-award Blanket Purchase Agreement (BPA) to Beckman Coulter, Inc. for microbiology cost-per-reportable-result testing services. The $702,494.50 BPA has a period of performance from October 1, 2024 through September 30, 2029 and was awarded in response to a solicitation issued by the Army Medical Command. The contract aims to procure commercial microbiology testing services, including the ability to properly identify certain organisms and test for...
This indefinite delivery contract (IDC) was awarded by the Naval Supply Systems Command (NAVSUP) to Center For Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings, to provide HIV-1+2 testing services. The single-award IDC has a ceiling value of $2,971,540 and a performance period ending on March 31, 2010. Several firm fixed-price delivery orders have been issued under the contract, totaling over $2.7 million, for HIV antibody and antigen screening services to be...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Quest Diagnostics Incorporated for surge serology testing services. The contract established a potential value of $23.75 million for Quest Diagnostics to provide COVID-19 antibody testing from its Secaucus, New Jersey laboratory in support of the CDC's pandemic response. A $14 million firm fixed price delivery order to Quest Diagnostics expanded the scope of work. Under the delivery order,...
The federal contract IDV is awarded to Center For Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings, by the U.S. Department of Defense's Readiness Center. The contract has a ceiling value of $65,000,000 and a period of performance ending on September 30, 2029. The contract is for the provision of medical laboratory testing services to detect the antigens and antibodies of Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antibody (HBsAb), Hepatitis B...
This federal contract IDV award to Bioscientia Institut FUR Medizinische Diagnostik GMBH, a for-profit organization, provides clinical reference laboratory testing services to the U.S. Defense Health Agency (DHA) and Department of the Army Medical Command. The Indefinite Delivery Contract (IDC), valued at up to $690,476.25, was awarded on May 1, 2022 and has an ultimate completion date of April 30, 2025. The contract serves as a vehicle for issuing delivery orders for these laboratory testing...
The Defense Logistics Agency Troop Support Medical awarded a single award Indefinite Delivery Contract to Cepheid, with a potential value of $790,119,750.00, to provide point-of-care nucleic acid amplification tests and analyzers. A $340 million firm fixed price delivery order was issued to Cepheid for their XPERT XPRESS SARS-COV-2/FLU/R tests, to be performed in Sunnyvale, California from April 1, 2022 through January 3, 2023. The originating solicitation sought proposals for multiple...